Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Rolling Out8 天
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
Knowridge2 天
Common drugs may affect memory function
The findings were alarming. People who took at least one anticholinergic drug had a 47% higher risk of developing memory ...
Dear Doctor: Can long-term use of gabapentin increase the chances of dementia?
For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral ...
Rolling Out9 天
5 ways this cancer drug could revolutionize Alzheimer’s treatment
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo ...
Eli Lilly ( LLY 1.80%) and Novo Nordisk ( NVO 2.76%) are two of the most valuable healthcare stocks in the world, largely due ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
When Head Trauma Wakes Dormant Viruses: A Hidden Risk for Alzheimer’s
A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...